Skip to main content
iMed Technologies
← Back to list
Conference

Our CEO Kono presents at the AI session of the JSNET Kanto Regional Meeting

We are pleased to announce that our CEO Kono presented "Real-time AI-assisted Neuroendovascular Therapy: Neuro-Vascular Assist" at the 24th Annual Meeting of the NPO Japanese Society of Neuroendovascular Therapy Kanto Regional Branch, Special Program 2 "The Future of Endovascular Therapy Pioneered by AI."

We are pleased to announce that our CEO Kono presented “Real-time AI-assisted Neuroendovascular Therapy: Neuro-Vascular Assist” at the 24th Annual Meeting of the NPO Japanese Society of Neuroendovascular Therapy Kanto Regional Branch, Special Program 2 “The Future of Endovascular Therapy Pioneered by AI.”

■About the 24th Annual Meeting of the NPO Japanese Society of Neuroendovascular Therapy Kanto Regional Branch The Annual Meeting of the JSNET Kanto Regional Branch is a regional meeting held in the Kanto area for physicians involved in neuroendovascular therapy. Our CEO Kono presented the company’s work in neuroendovascular therapy. The presentation was also streamed live. http://jsnetkanto24.umin.jp//special/index.html

■iMed Technologies, Inc. Company Profile

Company name: iMed Technologies, Inc.

Address: 2F Rune Yushima Building, 4-1-13 Yushima, Bunkyo-ku, Tokyo

Founded: April 1, 2019

Business: Development of surgical support AI for endovascular surgery

Representative: Representative Director and CEO, physician Kenichi Kono

Inquiries: info@imed-tech.co.jp